参考文献

［1］ Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener′s granulomatosis. Arthritis Rheum, 1990, 33 (8): 1101-1107.

［2］ Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener′s): an alternative name for Wegener′s granulomatosis. Arthritis Rheum, 2011, 63 (4): 863-864.

［3］ Charbonneau F, Williams M, Lafitte F, et al. No more fear of the cavernous sinuses!DiagnInterv Imaging, 2013, 94 (10): 1003-1016.

［4］ Keane JR. Cavernous sinus syndrome: analysis of 151 cases. Arch Neurol, 1996, 53 (10): 967-971.

［5］ Rotstein DL, Tyndel FJ, Tang-Wai DF. A case report of cavernous sinus syndrome in a patient with Takayasu′s arteritis. Headache, 2014, 54 (8): 1371-1375.

［6］ Fernández S, Godino O, Martínez-Yélamos S, et al. Cavernous sinus syndrome: a series of 126 patients. Medicine (Baltimore), 2007, 86 (5): 278-281.

［7］ Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener′s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol, 1993, 33 (1): 4-9.

［8］ 袁晶，关鸿志，吴庆军，等.韦格纳肉芽肿病神经系统损害33例临床特点分析.中华神经科杂志，2004，37 (5): 428-430.

［9］ 魏宸铭，刘智，赵静，等.左眼疼痛眼球活动受限7个月视力下降2个月.中国现代神经疾病杂志，2015，15 (5): 89-92. 3ZPi6lVMDD/ktCjS6e3YzrBhsTJmIuctyJYaXtdEzt6iQji+0j5T8qjQhklSRW0a